[{"id":"b7f25efd-6ae6-4639-9c74-62cd4da3cc28","acronym":"MALT","url":"https://clinicaltrials.gov/study/NCT03493230","created_at":"2021-01-18T17:12:08.128Z","updated_at":"2024-07-02T16:37:11.550Z","phase":"","brief_title":"Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT )","source_id_and_acronym":"NCT03493230 - MALT","lead_sponsor":"Centre Hospitalier Universitaire de Nice","biomarkers":" BRAF • NRAS","pipe":" | ","alterations":" BRAF mutation • NRAS mutation • NRAS mutation + BRAF mutation","tags":["BRAF • NRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF mutation • NRAS mutation • NRAS mutation + BRAF mutation"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 35","initiation":"Initiation: 04/01/2018","start_date":" 04/01/2018","primary_txt":" Primary completion: 04/01/2022","primary_completion_date":" 04/01/2022","study_txt":" Completion: 12/01/2022","study_completion_date":" 12/01/2022","last_update_posted":"2018-04-12"}]